These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37240584)

  • 1. Diagnostic Effectiveness of [
    Villena-Salinas J; Ortega-Lozano SJ; Amrani-Raissouni T; Agüera E; Caballero-Villarraso J
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.
    Vergnet S; Hives F; Foubert-Samier A; Payoux P; Fernandez P; Meyer M; Dupouy J; Brefel-Courbon C; Ory-Magne F; Rascol O; Tison F; Pavy-Le Traon A; Meissner WG
    Parkinsonism Relat Disord; 2019 Jun; 63():199-203. PubMed ID: 30745212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles.
    Furuta M; Sato M; Tsukagoshi S; Tsushima Y; Ikeda Y
    J Neurol Sci; 2022 Jul; 438():120281. PubMed ID: 35609364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type.
    Miyoshi F; Kanasaki Y; Shinohara Y; Fujii S; Kaminou T; Tanabe Y; Ogawa T
    Acta Radiol; 2016 Jun; 57(6):742-9. PubMed ID: 26253930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).
    Muñoz E; Iranzo A; Rauek S; Lomeña F; Gallego J; Ros D; Santamaría J; Tolosa E
    J Neurol; 2011 Dec; 258(12):2248-53. PubMed ID: 21633903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome.
    Warhadpande DS; Huo J; Libling WA; Stuehm C; Najafi B; Sherman S; Lei H; Roveda JM; Kuo PH
    Sensors (Basel); 2022 Jul; 22(13):. PubMed ID: 35808551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
    Schulz JB; Klockgether T; Petersen D; Jauch M; Müller-Schauenburg W; Spieker S; Voigt K; Dichgans J
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1047-56. PubMed ID: 8089667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy.
    Nicastro N; Garibotto V; Burkhard PR
    Clin Nucl Med; 2018 Feb; 43(2):e33-e36. PubMed ID: 29215405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
    Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature.
    González-Ávila C; Casado L; Muro García I; Villacieros-Álvarez J; Vivancos J; Quintas S
    Eur J Neurol; 2021 Apr; 28(4):1392-1395. PubMed ID: 33175431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MRI and
    Nishimori M; Murata Y; Iwasa H; Miyatake K; Tadokoro M; Kohsaki S; Nogami M; Hamada N; Ninomiya H; Osaki Y; Furuya H; Yamagami T
    Biomed Rep; 2018 Jun; 8(6):523-528. PubMed ID: 29774142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of the Visual Reading of
    Booij J; Dubroff J; Pryma D; Yu J; Agarwal R; Lakhani P; Kuo PH
    J Nucl Med; 2017 Nov; 58(11):1821-1826. PubMed ID: 28473597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of
    Murakami H; Kimura A; Yasumoto T; Miki A; Yamamoto K; Ito N; Momma Y; Owan Y; Yano S; Ono K
    Front Aging Neurosci; 2018; 10():412. PubMed ID: 30618718
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy.
    Virameteekul S; Revesz T; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Mov Disord; 2023 Mar; 38(3):444-452. PubMed ID: 36606594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.